Bioxyne Management

Management criteria checks 2/4

Bioxyne's CEO is Sam Watson, appointed in Nov 2023, has a tenure of 1.08 years. total yearly compensation is A$370.96K, comprised of 80.9% salary and 19.1% bonuses, including company stock and options. directly owns 30.99% of the company’s shares, worth A$16.51M. The average tenure of the management team and the board of directors is 1.6 years and 1.6 years respectively.

Key information

Sam Watson

Chief executive officer

AU$371.0k

Total compensation

CEO salary percentage80.9%
CEO tenure1.1yrs
CEO ownership31.0%
Management average tenure1.6yrs
Board average tenure1.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sam Watson's remuneration changed compared to Bioxyne's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$371kAU$300k

-AU$13m

Dec 31 2023n/an/a

-AU$13m

Sep 30 2023n/an/a

-AU$8m

Jun 30 2023AU$485kAU$25k

-AU$2m

Compensation vs Market: Sam's total compensation ($USD231.21K) is about average for companies of similar size in the Australian market ($USD289.43K).

Compensation vs Earnings: Sam's compensation has been consistent with company performance over the past year.


CEO

Sam Watson

1.1yrs

Tenure

AU$370,958

Compensation

Mr. Samuel Watson, also known as Sam, was Joint Chief Executive Officer of Bioxyne Limited from December 2022 until November 17, 2023 and serves as its Chief Executive Officer and Managing Director from No...


Leadership Team

NamePositionTenureCompensationOwnership
Samuel Watson
CEO, MD & Executive Director1.1yrsAU$370.96k30.99%
A$ 16.5m
Guy Robertson
CFO & Company Secretary8.3yrsAU$123.33k0.52%
A$ 275.7k
Jason Hine
COO & Executive Director1.6yrsAU$267.88k0.065%
A$ 34.4k
Naotaka Tei
Managing Director of BLS Japanno datano datano data
Rachel Qian
Financial Controller & Assistant Company Secretaryno datano datano data

1.6yrs

Average Tenure

Experienced Management: BXN's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Samuel Watson
CEO, MD & Executive Director1.6yrsAU$370.96k30.99%
A$ 16.5m
Jason Hine
COO & Executive Director1.6yrsAU$267.88k0.065%
A$ 34.4k
Anthony Ho
Non-Executive Independent Chairman12.2yrsAU$85.00k1.41%
A$ 748.9k

1.6yrs

Average Tenure

Experienced Board: BXN's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 04:35
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioxyne Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution